304 related articles for article (PubMed ID: 8789875)
1. Menopausal hormone replacement therapy and risk of breast cancer. Implications for the treatment of osteoporosis in postmenopausal women.
Lopes P
Rev Rhum Engl Ed; 1996 May; 63(5):309-11. PubMed ID: 8789875
[No Abstract] [Full Text] [Related]
2. [Estrogen substitution following the menopause and the risk of breast cancer; the importance of endogenous risk factors].
Russchen CJ
Ned Tijdschr Geneeskd; 1992 Jul; 136(28):1337-9. PubMed ID: 1635595
[No Abstract] [Full Text] [Related]
3. [Hormone replacement therapy and breast cancer--any news?].
Holli K
Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
[No Abstract] [Full Text] [Related]
4. [Prevention and treatment of postmenopausal osteoporosis in women treated for cancer].
Pratili MA; Gest-Laval C
Bull Cancer; 1992; 79(7):651-7. PubMed ID: 1467591
[TBL] [Abstract][Full Text] [Related]
5. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
Shintani M
Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
[TBL] [Abstract][Full Text] [Related]
6. [Conventional hormonal replacement therapy in treatment of osteoporosis].
Meczekalski B; Czyzyk A
Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
[TBL] [Abstract][Full Text] [Related]
7. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580
[No Abstract] [Full Text] [Related]
8. [Hormone replacement therapy following breast carcinoma].
Klijn JG; Bontenbal M
Ned Tijdschr Geneeskd; 1998 Jan; 142(3):113-7. PubMed ID: 9557007
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy: benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer.
Bluming AZ
Semin Oncol; 1993 Dec; 20(6):662-74. PubMed ID: 8296203
[No Abstract] [Full Text] [Related]
10. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
Genazzani AR; Schneider HP; Panay N; Nijland EA
Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
[TBL] [Abstract][Full Text] [Related]
11. Health risks after cessation of postmenopausal hormone therapy.
Pines A; Sturdee D; Birkhäuser M;
Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
[No Abstract] [Full Text] [Related]
12. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
Magnusson C; Weiderpass E
Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
[TBL] [Abstract][Full Text] [Related]
13. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
Higuchi T; Mizunuma H
Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
[TBL] [Abstract][Full Text] [Related]
14. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
Brettes JP; Mathelin C
Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
[No Abstract] [Full Text] [Related]
15. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
16. [Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast].
Burger CW; Koomen I; Peters NA; van Leeuwen FE; Kenemans P
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):368-72. PubMed ID: 9157296
[TBL] [Abstract][Full Text] [Related]
17. [Breast carcinoma and later hormonal osteoporosis prevention].
Obrecht JP
Dtsch Med Wochenschr; 1992 Oct; 117(42):1615-6. PubMed ID: 1396160
[No Abstract] [Full Text] [Related]
18. Postmenopausal estrogen replacement therapy in the patient with breast carcinoma.
Cyr MG
R I Med; 1995 Sep; 78(9):261-3. PubMed ID: 7579723
[No Abstract] [Full Text] [Related]
19. Benefits and risks of hormone/estrogen replacement.
Thomas DJ
Nurs Clin North Am; 1996 Dec; 31(4):815-25. PubMed ID: 8969341
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
